Steward Partners Investment Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.46M Buy
72,108
+8,917
+14% +$796K 0.04% 428
2026
Q1
$4.54M Buy
63,191
+2,335
+4% +$180K 0.02% 544
2025
Q4
$4.83M Buy
60,856
+1,192
+2% +$94K 0.03% 482
2025
Q3
$4.5M Sell
59,664
-12
-0% -$822 0.03% 494
2025
Q2
$4.12M Sell
59,676
-939
-2% -$61.6K 0.03% 479
2025
Q1
$4.11M Sell
60,615
-1,490
-2% -$89.2K 0.04% 457
2024
Q4
$2.79M Sell
62,105
-28,720
-32% -$1.61M 0.02% 536
2024
Q3
$5.71M Sell
90,825
-11,351
-11% -$662K 0.05% 331
2024
Q2
$6.03M Sell
102,176
-11,358
-10% -$710K 0.06% 296
2024
Q1
$9.06M Buy
113,534
+19,337
+21% +$1.48M 0.1% 214
2023
Q4
$7.44M Sell
94,197
-16,724
-15% -$1.19M 0.1% 211
2023
Q3
$7.74M Sell
110,921
-17,432
-14% -$1.24M 0.12% 180
2023
Q2
$8.87M Sell
128,353
-38,491
-23% -$2.74M 0.13% 164
2023
Q1
$12.4M Sell
166,844
-63,976
-28% -$5.36M 0.2% 114
2022
Q4
$21.5M Sell
230,820
-2,651
-1% -$256K 0.37% 57
2022
Q3
$22.3M Buy
233,471
+20,516
+10% +$2.03M 0.42% 50
2022
Q2
$19.7M Buy
212,955
+2,472
+1% +$241K 0.36% 61
2022
Q1
$21.3M Sell
210,483
-7,821
-4% -$822K 0.33% 67
2021
Q4
$22.5M Buy
218,304
+5,626
+3% +$520K 0.34% 61
2021
Q3
$18M Sell
212,678
-14,875
-7% -$1.25M 0.31% 71
2021
Q2
$19M Buy
227,553
+25,056
+12% +$2.05M 0.32% 64
2021
Q1
$15.2M Buy
202,497
+5,720
+3% +$417K 0.27% 88
2020
Q4
$13.4M Buy
196,777
+15,325
+8% +$997K 0.29% 84
2020
Q3
$10.6M Sell
181,452
-26,664
-13% -$1.66M 0.27% 95
2020
Q2
$13.5M Buy
208,116
+6,300
+3% +$397K 0.39% 59
2020
Q1
$12M Buy
201,816
+59,204
+42% +$3.95M 0.44% 53
2019
Q4
$10.6M Buy
142,612
+4,902
+4% +$344K 0.31% 75
2019
Q3
$8.69M Buy
137,710
+72,173
+110% +$4.28M 0.29% 83
2019
Q2
$3.57M Buy
65,537
+16,243
+33% +$875K 0.13% 165
2019
Q1
$2.66M Sell
49,294
-17,785
-27% -$1.1M 0.11% 189
2018
Q4
$4.39M Buy
67,079
+31,774
+90% +$2.37M 0.21% 114
2018
Q3
$2.78M Buy
35,305
+12,804
+57% +$915K 0.13% 173
2018
Q2
$1.45M Sell
22,501
-4,259
-16% -$281K 0.09% 234
2018
Q1
$1.66M Buy
26,760
+1,181
+5% +$84.7K 0.11% 198
2017
Q4
$1.85M Buy
25,579
+8,783
+52% +$639K 0.14% 161
2017
Q3
$1.36M Buy
16,796
+237
+1% +$18.7K 0.14% 151
2017
Q2
$1.33M Buy
16,559
+4,563
+38% +$360K 0.15% 150
2017
Q1
$941K Buy
11,996
+7,568
+171% +$604K 0.14% 132
2016
Q4
$349K Buy
+4,428
New +$358K 0.16% 133

Other funds holding CVS

Steward Partners Investment Advisory's CVS Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its CVS Health (CVS) stake by 14% in Q2 2026, buying an estimated $796K and bringing the position to 72,108 shares worth $7.46M. The position accounts for 0.04% of the portfolio, ranked #428.

Steward Partners Investment Advisory first reported a position in CVS in Q4 2016 and has held it in 39 quarters since. The position peaked at $22.5M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Steward Partners Investment Advisory held 72,108 shares of CVS Health worth $7.46M as of Q2 2026.
  • Steward Partners Investment Advisory bought 8,917 CVS Health shares in Q2 2026, an estimated $796K.
  • CVS Health made up 0.04% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #428 holding.
  • Steward Partners Investment Advisory first reported a position in CVS Health in Q4 2016 and has held it in 39 quarters since.
  • Steward Partners Investment Advisory's CVS Health position peaked at $22.5M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.